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Abstract
Background: In 2003, nosocomial infections caused by vancomycin-resistant enterococci (VRE) occurred rarely
in Taiwan. Between 2003 and 2010, however, the average prevalence of vancomycin resistance among
enterococci spp. increased from 2% to 16% in community hospitals and from 3% to 21% in medical centers
of Taiwan. We used molecular methods to investigate the epidemiology of VRE in a tertiary teaching hospital
in Taiwan.
Methods: Between February 2009 and February 2011, rectal samples and infection site specimens were
collected from all inpatients in the nephrology ward after patient consent was obtained. VRE strain types were
determined by pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST).
Results: A total of 59 vanA gene-containing VRE isolates (1 per patient) were obtained; 24 originated from
rectal sample surveillance of patients who exhibited no symptoms (22 Enterococcus faecium and 2 Enterococcus
faecalis), and 35 had developed infections over 3 days after admission (32 E. faecium, 2 E. faecalis, and 1
Enterococcus durans). The 59 VRE isolates demonstrated vancomycin minimum inhibitory concentrations (MICs)
of ≥256 μg/m. The MIC range for linezolid, tigecycline, and daptomycin was 0.25–1.5 μg/mL, 0.032–0.25 and
1–4 μg/mL, respectively. For 56 isolates, the MIC for teicoplanin was >8 μg/mL. The predominant types in the
nephrology ward were MLST types 414, 78, and18 as well as PFGE types A, C, and D.
Conclusion: VREs are endemic in nephrology wards. MLST 414 is the most predominant strain. The increase
VRE prevalence is due to cross-transmission of VRE clones ST 414,78,18 by undetected VRE carriers. Because
similar VRE STs had been reported in a different hospital of Taiwan, this finding may indicate inter-hospital VRE
spread in Taiwan. Active surveillance and effective infection control policies are important controlling the
spread of VRE in high risk hospital zones. All endemic VRE strains are resistant to teicoplanin but are sensitive
to daptomycin, linezolid, and tigecycline.
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Background
For most immunocompetent patients, colonization with
vancomycin-resistant enterococci (VRE) does not present
a significant personal health risk; however, these patients
may function as carriers, and following hospital admission,
may pose a substantial risk for transmission [1-4]. In 2003,
nosocomial infections caused by VRE occurred rarely in
Taiwan [5]. Between 2003 and 2010, however, the preva-
lence of vancomycin resistance among enterococci spp. in
community-hospitals and medical centers has increased
from 2% to 16% and from 3% to 21%, respectively [5].
Little is known about the epidemiology of VRE, and most
information has derived from the descriptions of mono-
clonal outbreaks [6-11]. The reasons underlying the rapid
emergence of VRE had not been investigated in Taiwan
thus far. Taiwan’s current management guidelines for VRE
colonization and infection mimic those of the United
States, which involve reasonably strict isolation measures
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[3,6]. The complete enforcement of these policies for
VRE-colonized patients is difficult and impractical; the
isolation rooms in most teaching hospitals are inadequate
and high in cost [7]. Thus, we used multi-locus sequence
typing (MLST) and pulsed-field gel electrophoresis (PFGE)
to assess the epidemiology of VRE in a hospital setting,
investigate the need for these policies, and discover new
VRE clones. We also investigated the in-vitro susceptibil-
ities of VRE to current antimicrobial agents.
Methods
Setting and study design
Chang Gung Memorial Hospital at Keelung in Taiwan is
a 1088-bed, tertiary-care, teaching hospital. The preva-
lence of vancomycin resistance among enterococci spp.
in this hospital rose from 10% in 2003 to 30% in 2009,
and it was most pronounced in the nephrology ward. A
VRE outbreak was suspected in the nephrology ward be-
cause the prevalence rate, 30%, was higher than the aver-
age rate,16%, in Taiwan [5]. This research plan was
approved by the Human Trial and Ethics Committee of
Chang Gung Memorial Hospital on December 24, 2008
(reference number 97-2117B). Between February 2010
and February 2011, a VRE surveillance study was con-
ducted on both hemodialysis and non-hemodialysis in-
patients in the nephrology ward of this hospital. Rectal
swab cultures for VRE were collected from all nephrol-
ogy inpatients during admission after patient consent
was obtained. Colonization was defined as VRE isolation
from rectal swabs in the absence of infection symptoms
or signs. Infection was defined as VRE isolation from a
sterile or non-sterile site along with the presentation of
fever, leukocytosis, and other signs caused by the VRE.
All VRE-infected patients were confined to a single
room or a double room with two beds for 2 VRE-infected
patients of the same sex. All health-care workers (HCW)
who administered care on VRE-infected patients were
asked to follow infection control policies during patient
care, including hand washing and glove and gown wearing
when necessary [12]. During this study period, active sur-
veillance was performed on inpatients of the nephrology
ward after patient consent was obtained. Further, within
this study period, potential VRE specimens were collected
both from HCWs after they provided consent and from
the nephrology ward environment, including bedrails, pil-
lows, tables, door handles, blood-pressure cuffs, ventilator
monitor surfaces, and the surfaces of medical devices such
as EKG monitors. All VRE strains isolated from inpatients,
HCWs, and the environment were stored until needed for
epidemiological and antibiotic susceptibility studies.
Identification of VRE
All rectal swabs were cultured on blood agar plates,
which were examined after 48 h of incubation at 37°C.
The colonies were identified as those of Enterococcus spp.
based on known enterococcus characteristics, including
the presence of gram-positive cocci, optochin resistance,
bile-esculin color change to black, and growth in 6.5% so-
dium chloride (NaCl) [1,2]. Specific enterococcus spp. were
identified by differential utilization of arginine, sorbitol,
arabinose, and raffinose and by the rapid 32 Strep kit test
(bioMerieux Vitek Inc., Hazelwood, Missouri, USA) [1,2].
VRE presence was confirmed by growth in brain heart in-
fusion agar that contained 6 μg/mL vancomycin [13,14].
Pulsed-field gel electrophoresis
For PFGE analysis, the isolates were inoculated into 5-
mL nutrient broth and incubated for 3 h at 37°C with
shaking to achieve exponential growth. Agarose plugs
were prepared from the cultures, and within the plugs,
the bacterial cells were lysed by proteinase K. Extracted
genomic DNA was digested with the restriction endo-
nuclease SmaI [15,16]. The resulting restriction frag-
ments were separated by PFGE using the MAPPER
system (Bio-Rad Laboratory, Hercules, CA, USA). Band
patterns were analyzed to determine clonal identity. Pre-
viously described criteria were used for the analysis of
genomic DNA [15,16].
Multilocus sequence typing
VRE isolates were typed by MLST. With the use of the
Ibis T5000™ Biosensor System (Abbott, USA), we ampli-
fied 7 selected gene fragments that encode 7 housekeeping
proteins by broad-range polymerase chain reaction (PCR).
The base compositions of the amplicons were determined
by electrospray ionization mass spectrometry. The base
compositions of different target regions are shown by
mass spectrometry and were used to create a signature
that distinguished strains from one another [17].
Genotypic analysis of resistance pattern of VRE
To identify possible additional epidemiological markers,
we investigated the presence of vanA, vanB, vanC1, and
vanC2 genes by PCR. The PCR primer sequences were
based on the published genes for Enterococcus faecalis,
Enterococcus faecium, and Enterococcus gallinarum [18,19].
Antibiotic susceptibility
The VRE isolate MICs for 8 antimicrobial agents, including
daptomycin (Cubist Pharmaceuticals), fusidic acid (Leo),
linezolid (Pfizer), mupirocin (GlaxoSmithKline), teico-
planin (Sanofi-Aventis), tigecycline (Pfizer), trimethoprim/
sulfamethoxazole (Sandoz), and vancomycin (Eli Lilly),
were determined by Etest (AB Biodisk, Solna, Sweden)
according to the published guidelines [13,14]. The MIC
ranges for these antibiotics were as follows: daptomy-
cin, 0.002–32 μg/mL; fusidic acid, 0.016–256 μg/mL;
linezolid, 0.016–256 μg/mL; mupirocin, 0.064–1024 μg/
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mL; teicoplanin, 0.016–256 μg/mL; tigecycline, 0.016–
256 μg/mL; trimethoprim/sulfamethoxazole, 0.002–32
μg/mL; and vancomycin, 0.016–256 μg/mL. As a con-
trol strain, E. faecalis ATCC 29212 was included with
acceptable MIC limits according to CLSI M100-S19
(January 2009): daptomycin, 1–4 μg/mL; linezolid, 1–4
μg/mL; teicoplanin, 0.125–0.5 μg/mL; tigecycline, 0.03–
0.12 μg/mL; and vancomycin, 1–4 μg/mL.
Results and discussion
A total of 59 VRE isolates were obtained from 59 pa-
tients (Table 1). For surveillance purposes, 101 rectal
swabs were collected and cultured from 101 inpatients
after admission; 24 of these inpatients were culture-
positive for VRE. These 24 VRE isolates were indicative
of colonization without any clinical symptoms or signs
of VRE infection and all carried the vanA gene (22
E. faecium and 2 E. faecalis isolates). The remaining 35
isolates were discovered from 35 in patients with clini-
cally manifested infections caused by VRE. All these 35
infections caused by VRE developed over 3 days after
admission and were considered as healthcare-associated
infections. These 35 isolates of VRE causing infections
also carried the vanA gene and consisted of 32
E. faecium, 2 E. faecalis and 1 E. durans. Of the 54
E. faecium isolates, 35 were type ST 414, 9 were ST 18,
4 were ST 78, 3 were ST 203, 2 were ST 341, and 1 was
ST 556 (Table 1). Of the 35 ST 414 E. faecium isolates,
17 were PFGE subtype A3, 8 were subtype A4, 5 were
subtype A1, 3 were subtype A5, 1 was subtype A2, and 1
was subtype A6 (Table 1). Of the 9 ST 18 E. faecium iso-
lates, 5 were PFGE subtype D1, 2 were subtype D2, and
2 were subtype D3 (Table 1). The PFGE types of
remaining ST types of E. faecium isolates belonged to
types B through F: 3 B1, 1 C1, 2 C2, 1 C3, 2 E1, and 1
F1 (Table 1). Of the 4 E. faecalis isolates, 3 were ST 414
and 1 was ST 203. The PFGE subtypes of these 3 ST 414
E. faecalis isolates were identical, G1 (Table 1). The single
E. durans isolate belonged to ST 341. The 24 colo-
nized VRE isolates and the 35 infection isolates all were
discovered in the same nephrology ward that was under
the care of the same medical team, including attending
physicians, resident doctors, and nurses within the study
period, February 2010 through February 2011. These
pieces of epidemiologic evidence strongly support that
cross-transmission had occurred in the nephrology ward.
Of the 227 samples potentially containing VRE that
were collected from the environment and medical de-
vices, only 1 VRE isolate was discovered on a patient pil-
low. The room of this patient had hosted a VRE-infected
patient within the same week. This environmental VRE
isolate was identified as E. faecium MLST 414 and PFGE
type A3. Only 23 nurses and 2 resident doctors consented
to hand culture for bacteria, and all cultures were negative.
ST types 414, 18, and 78 were isolated from both colo-
nized and infected patients (Table 1). Epidemiologic links
evident among similar VRE ST types of colonized and
infected patients and the environment indicate that this
VRE outbreak most likely was due to cross transmission
from the inpatients and the environment—probably ori-
ginating from undetected VRE carriers.
Of the 59 VRE isolates, 56 demonstrated teicoplanin
MIC of >8 μg/mL (Table 1). The MIC range was 0.25–
1.5 μg/mL for linezolid, 0.032–0.25 μg/mL for tigecycline,
and 1–4 μg/mL for daptomycin.
This study revealed a close relationship between VRE
colonization and VRE symptomatic infections; similar
ST types (414, 78, 18, and 341) and PFGE types (A, C,
D, and E) were identified in patients both asymptomatic
for and clinically manifested VRE. This finding indicates
that infection control policies for VRE will not be suc-
cessful if the policy includes clinically manifested VRE
infections and excludes asymptomatic VRE colonization.
If the infection control policy also includes asymptom-
atic VRE colonization, then active VRE surveillance will
be required. Further study is needed to evaluate the tim-
ing and conditions under which active VRE surveillance
should be initiated and can be proven as cost-effective.
Although we had discovered only 1 VRE isolate from the
environment, other possible environmental sites for con-
tamination still exist; chairs and couches can become
contaminated via perianal contact [7]. For HCWs ad-
ministering care to VRE patients, the most common
sites of contamination were gowns and gloves according
to a prior report [7]. Because only 1 VRE isolate was dis-
covered from the environment in this study, cross trans-
mission of VRE in the nephrology ward may occur via
HCWs, including resident doctors and attending phys-
ician, who refused the hand culture for bacteria. Al-
though we were unable to isolate VRE from the 23
nurses and 2 doctors who had consented to hand cul-
ture, the patients’ hands apparently are a frequent site of
contamination [20,21]. Routine patient use of alcohol-
chlorhexidine hand gel or appropriate hand-washing prac-
tices upon entry to and departure from the hemodialysis
area and nephrology ward should be encouraged [3,6].
The links between VRE acquisition and the hospital envi-
ronment is recognized in current patient care guidelines,
which seek to limit VRE transmission [1,6].
Cho et al. in Korea reported VRE ST 192, ST 78, ST
17, and ST 414 (highest to lowest frequency) in 2011
[22]. In our study, however, VRE ST 414 was the most
frequent type. In Taiwan, Lu et al. performed MLST on
149 VRE blood isolates obtained between 2003 and 2010
[23]. Between 2009 and 2010, ST 18 and ST 414 were
the 2 predominant STs, and accounted for 29.7% and
25.0% of all isolates, respectively [23]; however, the epi-
demiological relationships between these ST types were
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Site of specimen(N) MIC ug/ml mean/range
Van Teic Fusi Mup Line *TS Tige Dapt
Inf (32) (E.faecium) (+) 414(19) A3(8) B(2),P(3) U(3) >256 157.8/6- > 256 2.18/1.5-3 0.50/0.38-1 0.99/0.38-1.5 >32 0.07/0.047-0.125 1.66/0.8-2
A4(6) B(1), C(1), P(1), U(2), W(1), >256 192.67/4- > 256 2.17/1.5-3 0.42/0.38-0.5 0.73/0.38-1 >32 0.067/0.047-0.094 2.42/1.5-3
A5(3) U(2),W(1) >256 >256 3/3-3 0.42/0.38-0.5 1.17/1-1.5 >32 0.064/0.064-0.064 2.17/1.5-3
A1(2) W(2) >256 >256 2.5/2-3 0.38/0.25-0.5 0.88/0.75-1 >32 0.064/0.064-0.064 2/2-2
18(8) D1(4) B(1), P(1), U(1) W(1), >256 148/32- > 256 1.88/1.5-2 0.38 0.25-0.5 0.66/0.38-1 16.04/0.032- > 32 0.17/0.094-0.38 2.25/2-3
D2(2) U(2) >256 192/128- > 256 2/2-2 0.25/0.25-0.25 1/0.5-1.5 16.02/0.032- > 32 0.11/0.094-0.125 3.5/1-6
D3(2) B(1), W(1) >256 72/48-96 2.5/2-3 0.38/0.38-0.38 0.75/0.5-1 16.13/0.25- > 32 0.11/0.094-0.125 2.75/1.5-4
78(3) C1(1) U(1) >256 32 3 0.38 0.25 >32 0.125 3
C2(1) U(1) >256 64 1.5 0.25 0.38 >32 0.064 3
C3(1) W(1) >256 16 1.5 0.25 0.38 >32 0.064 4
341(1) E1(1) U(1) >256 >256 2.0 0.5 1.5 >32 0.094 2
556(1) F1(1) U(1) >256 128 3 0.38 1.5 >32 0.064 2
Col (22) (E.faecium) (+) 414(16) A3(9) RS(9) >256 194.7/24-256 2.72/1.5-4 2.11/0.25-16 0.83/0.25-1.5 >32 0.08/0.047-0.19 2.39/1.5-4
A1(3) RS(3) >256 213.33/128-256 3/3-3 0.46/0.38-0.5 1.08/0.75-1.5 >32 0.07/0.047-0.094 2.33/2-3
A4(2) RS(2) >256 >256 2.25/1.5-3 0.5/0.5-0.5 0.63/0.25-1 >32 0.055/0.047-0.064 3/2-4
A2(1) RS(1) >256 24 3 0.38 1 >32 0.047 3
A6(1) RS(1) >256 >256 2 0.5 1.5 >32 0.25 1.5
203(3) B1(3) RS(3) >256 85.3/64-128 1.71/0.1-3 0.42/0.38-0.5 1.06/0.5-1.5 >32 0.146/0.125-0.19 3.17/1.5-4
18(1) D1(1) RS(1) >256 32 4 0.5 0.5 >32 0.125 1
78(1) C2(1) RS(1) >256 128 2 0.38 1 >32 0.064 2
341(1) E1(1) RS(1) >256 >256 3 0.38 1 >32 0.047 2
Inf (2) (E.faecalis) (+) 414(2) G1(2) U(1), W(1) >256 18/12-24 2/2-2 0.38/0.38-0.38 1.25/1.0-1.5 >32 0.055/0.047-0.064 1.75/1.5-2
Col (2) (E.faecalis) (+) 414(1) G1 (1) RS(1) >256 >256 2 0.5 1.5 >32 0.094 4
203(1) H1(1) RS(1) >256 128 2 0.5 1.5 >32 0.19 4
Inf (1) (E.durans) (+) 341(1) I1(1) U(1) >256 96 3 0.5 1 >32 0.047 1.5
Inf, infection; Col, colonization; MLST, multilocus sequence typing; PFGE, pulsed-field gel electrophoresis.
B, blood, C, catheter tip, P, pus, RS, rectal swab, U, urine, W, wound.



















not reported. In our study, we reported an outbreak of
VRE colonization and infection caused by ST 414 and
18. The identification of similar VRE STs in different
hospitals of the same country may indicate inter-hospital
VRE spread in Taiwan. Similar VRE STs were detected
in Korean and Taiwanese hospital, which indicates that
international spread of VRE is possible. An effective in-
fection control policy is needed to prevent inter-hospital
and international VRE spread.
Conclusions
In Taiwan, increased VRE prevalence is due to cross
transmission of VRE clones ST 414, 78, and 18 from un-
detected VRE carriers. To avoid cross transmission of
VRE in hospital wards, an infection control policy for
VRE should include asymptomatic VRE colonization,
and thus, active surveillance of VRE during admission;
subsequent isolation and appropriate hand-washing prac-
tices may be necessary to prevent the spread of VRE
within a hospital. Because similar VRE STs had been
reported in a different hospital of Taiwan, inter-hospital
VRE spread may exist in Taiwan. Because of the high like-
lihood of environmental contamination by VRE-colonized
or VRE-infected inpatients, we believe it is imperative that
the ward environments are cleaned thoroughly on a daily
basis throughout a VRE patient’s hospitalization and also
after discharge.
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